Correlation Between Vee SA and Medicofarma Biotech

Can any of the company-specific risk be diversified away by investing in both Vee SA and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vee SA and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vee SA and Medicofarma Biotech SA, you can compare the effects of market volatilities on Vee SA and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vee SA with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vee SA and Medicofarma Biotech.

Diversification Opportunities for Vee SA and Medicofarma Biotech

0.76

Correlation Coefficient

Vee SA  Medicofarma Biotech

Poor diversification

The 3 months correlation between Vee and Medicofarma is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Vee SA and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and Vee SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vee SA are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of Vee SA i.e., Vee SA and Medicofarma Biotech go up and down completely randomly.

Pair Corralation between Vee SA and Medicofarma Biotech

Assuming the 90 days trading horizon Vee SA is expected to under-perform the Medicofarma Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Vee SA is 1.43 times less risky than Medicofarma Biotech. The stock trades about -0.18 of its potential returns per unit of risk. The Medicofarma Biotech SA is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  57.00  in Medicofarma Biotech SA on September 2, 2024 and sell it today you would lose (19.00) from holding Medicofarma Biotech SA or give up 33.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vee SA  vs.  Medicofarma Biotech SA

Vee SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vee SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Vee SA and Medicofarma Biotech

The main advantage of trading using opposite Vee SA and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vee SA position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.

The idea behind Vee SA and Medicofarma Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.